Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for REFR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain Nasdaq listing compliance | A primary condition in Research Frontiers Inc's published investment case. The stated target is no delisting or failure to satisfy listing rules over next 12 months. | Under Pressure | company is delisted or fails to meet Nasdaq listing standards | Nasdaq deficiency notice received Nasdaq issued deficiency letters on June 2, 2026, citing failure to satisfy continued listing rules. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative, loss-making company rather than an established compounder. The multi-year view is on watch: recent performance is weak, although the composite insight improved and the thesis has not freshly broken.
The valuation model indicates REFR is expensive versus peers, with a large expectations gap, but model confidence is low. The evidence points to optionality, meaning value tied to possible future outcomes, as a key valuation driver; it does not show that investors have priced in a successful turnaround.
Near-term fundamentals remain pressured: operating losses have worsened, cash from operations has been negative, and the company raised capital through a private placement. Management is also addressing a Nasdaq listing deficiency, while its record of managing losses remains behind. The broader sector backdrop is neutral, and the near-term risk assessment is quiet, but the company’s small size and history of a deep miss remain concerns.
The multi-year thesis hinges on whether the company can reduce operating losses, improve cash flow, and maintain listing compliance. In the near term, rate cuts or stabilization among larger technology companies could support the sector backdrop; materially slower GDP growth could weigh on growth-sensitive technology names.
Over the next 1 to 3 years, REFR’s thesis rests on operating improvement and regulatory progress, while persistent losses and high risk leave the evidence for a durable recovery limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Despite losses, this partnership could drive future revenue growth. |
| Improving |
| partnerships fail to deliver new product or market progress |
Qualitative: 1 new partnership (Klim) vs target of measurable growth Klim partnership announced; Nasdaq delisting notice received; private placement completed. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue growth recovers above -55% decline | A primary condition in Research Frontiers Inc's published investment case. The stated target is revenue decline less severe than -55% next 12 months. | Broken | revenue decline exceeds -55% next 12 months | Revenue growth: -33.53% FY2026-Q2; GAAP. Published target: revenue decline less severe than -55% next 12 months. Target period is not explicitly aligned with this observation. Aug 6, 2026-33.530915 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.07 → $-0.07 · observed estimates
$0.00B → $0.00B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-25 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-26 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-27 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-28 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-29 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-30 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-07-31 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-01 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-02 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-03 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-04 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-05 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-06 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-08 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-09 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-10 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-12 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-13 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-14 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-15 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-16 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-17 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-18 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-19 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-20 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-21 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-22 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-23 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-24 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-25 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-26 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-27 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-28 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-29 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-30 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-08-31 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-01 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-02 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-03 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-04 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-05 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-06 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-07 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-08 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-09 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-10 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-11 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-12 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-13 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-14 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-15 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-16 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-17 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-18 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-19 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-20 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-21 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-22 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-23 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-24 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-25 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-26 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-27 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-28 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-29 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-09-30 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-01 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-02 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-03 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-04 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-05 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-06 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-07 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-08 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-09 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-10 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-11 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-12 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-13 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-14 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-15 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-16 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-17 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-18 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-19 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-20 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-21 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-22 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-23 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-24 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-25 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-26 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-27 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-28 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-29 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-30 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-10-31 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-11-01 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-11-02 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-11-03 | $-0.07 | $1,790,000 | 1 / 1 |
| 2026-11-04 | $-0.07 | $1,790,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.